Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.

Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases

Shi, Yufang, Wang, Yu, Li, Qing, Liu, Keli, Hou, Jianquan, Shao, Changshun, Wang, Ying · 2018 · Nature Reviews Nephrology

Abstract

Mesenchymal stem cells (MSCs; also referred to as mesenchymal stromal cells) have attracted much attention for their ability to regulate inflammatory processes. Their therapeutic potential is currently being investigated in various degenerative and inflammatory disorders such as Crohn's disease, graft-versus-host disease, diabetic nephropathy and organ fibrosis. The mechanisms by which MSCs exert their therapeutic effects are multifaceted, but in general, these cells are thought to enable damaged tissues to form a balanced inflammatory and regenerative microenvironment in the presence of vigorous inflammation. Studies over the past few years have demonstrated that when exposed to an inflammatory environment, MSCs can orchestrate local and systemic innate and adaptive immune responses through the release of various mediators, including immunosuppressive molecules, growth factors, exosomes, chemokines, complement components and various metabolites. Interestingly, even nonviable MSCs can exert beneficial effects, with apoptotic MSCs showing immunosuppressive functions in vivo. Because the immunomodulatory capabilities of MSCs are not constitutive but rather are licensed by inflammatory cytokines, the net outcomes of MSC activation might vary depending on the levels and the types of inflammation within the residing tissues. Here, we review current understanding of the immunomodulatory mechanisms of MSCs and the issues related to their therapeutic applications.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41581-018-0023-5

Cites

158 of 158 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 158 references

Cited by

See all 1,223

Metadata

Authors
Shi, Y., Wang, Y., Li, Q., Liu, K., Hou, J., Shao, C., & Wang, Y.
Affiliations
  • Shanghai Jiao Tong University (CN)
  • Soochow University (CN)
Corresponding author
  • Shi, Yufang
  • Wang, Yu
  • Wang, Ying
Venue
Nature Reviews Nephrology
Published
2018-06-12
Volume
14
Issue
8
Pages
493-507
ISSN
  • 1745-8323 (ISSN-L)
  • 1759-5061
  • 1759-507X
OpenAlex
W2808158796
Cited by
1,223
References
158
Citations by year
2026: 91 · 2025: 137 · 2024: 207 · 2023: 199 · 2022: 233 · 2021: 186 · 2020: 112 · 2019: 48 · 2018: 9
FWCI
12.93
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Reviews Nephrology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Chinese Academy of Sciences
  • National Key Research and Development Program of China
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords
mesenchymal stem cells, immunomodulation, inflammation, inflammatory diseases, Crohn's disease, graft-versus-host disease, diabetic nephropathy, organ fibrosis, exosomes, chemokines, complement proteins, regenerative microenvironment, cell therapy
MeSH terms
Animals, Graft vs Host Disease, Humans, Immunity, Innate, Inflammation, Kidney Diseases, Lymphocytes, Phagocytes, Cytokines, Stromal Cells, Mesenchymal Stem Cell Transplantation, Indoleamine-Pyrrole 2,3,-Dioxygenase, Nitric Oxide Synthase Type II, Immunomodulation, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. https://app.cochat.ai/papers/10.1038/s41581-018-0023-5
The paper
Shi, Y., Wang, Y., Li, Q., Liu, K., Hou, J., Shao, C., & Wang, Y. (2018). Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nature Reviews Nephrology. https://doi.org/10.1038/s41581-018-0023-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.